1YKi-Jarvinen H. Pathogeresis of non-insulion-dependent diabetes mellitus. Ladcet, 1994,343:91-95.
2Swinbin BA, Gianchandani R,Saad MF, et al. In vivo beta cell function at the transition to ealy non-insulin-dependent diabetes mellitus. Metablism, 1995, 44: 757-764.
3Leshy JL, Weir Gc. Beta cell dysfunctron in hyperglycemia ratmidel: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabtologia, 1991,34:640-647.
8张晓庆.药剂人员如何区分与掌握临床常用胰岛素注射剂[J].Herald of Medicine Vol.29 Suppl.August 2010,204-205.
9Boehm B,Home P,Behread C.Premixed insulin aspart 30 vs premixed\shuman insulin 30/70 twice daily:a randomized trail in type 1 and type2 diabetic patients[J].Diabetic Medicine,2002,(05):393-399.doi:10.1046/j.1464-5491.2002.00733.x.
10Weyer C,Heise T,Heinemann L.Insulin aspart in a 30/70 premixed\sformulation.Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture[J].Diabetes Care,1997.1612-1614.doi:10.2337/diacare.20.10.1612.
